Aijun Jiang
Xuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The genetic repertoire of deep-sea microbiome: From sequence to structure and function.
Journal: Cell host & microbe
Published: June 03, 2025
Single-nucleus and spatial transcriptomics identify brain landscape of gene regulatory networks associated with behavioral maturation in honeybees.
Journal: Nature communications
Published: January 29, 2023
High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: A systematic review and meta-analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 01, 2022
Hologenome analysis reveals independent evolution to chemosymbiosis by deep-sea bivalves.
Journal: BMC biology
Published: October 31, 2022
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 20, 2022
The Value of Anlotinib in the Treatment of Intractable Brain Edema: Two Case Reports.
Journal: Frontiers in oncology
Published: October 15, 2020
Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: June 26, 2020
Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study.
Journal: Radiation oncology (London, England)
Published: February 01, 2020
Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases.
Journal: Radiation oncology (London, England)
Published: September 10, 2018
Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma.
Journal: Cancer medicine
Published: April 23, 2018
Last Updated: 09/26/2026